Along similar lines, disease-linked variants of UBR4 have been identified in patients suffering from episodic ataxia (EA), a neurological disorder that is associated with altered biosynthesis and trafficking of calcium and potassium channels to the PM47–52. Here, UBR4 is linked to nervous system disorder.